Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
JDOCvsIHEETF Comparison
JPMorgan Healthcare Leaders ETF (JDOC) belongs to the Global Blended Cap segment. iShares U.S. Pharmaceuticals ETF (IHE) is part of the US Health Care segment. JDOC's top 3 sector exposures are Health Care and Consumer Discretionary. In contrast, IHE's top sector exposures are Health Care JDOC is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.38% for IHE. JDOC is down -4.05% year-to-date (YTD) with - in YTD flows. IHE performs better with 2.1% YTD performance, and +$129M in YTD flows. Run a side-by-side ETF comparison of JDOC and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
JDOC vs IHE performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | JDOC IHE | -5.93%-4.25% | -4.12%+1.32% | -4.05%+2.10% | +6.14%+27.98% | n/a+59.87% | n/a+56.57% |
| Flows | JDOC IHE | -+$5M | -+$142M | -+$129M | -$85K+$248M | -+$359M | -+$393M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | JDOC IHE | +13.07%+16.09% | +16.33%+20.46% | n/a+15.96% | n/a+15.82% |
| Max drawdown | JDOC IHE | -7.03%-5.75% | -11.54%-14.18% | n/a-16.04% | n/a-16.12% |
| Max drawdown duration | JDOC IHE | 50d12d | 192d150d | n/a210d | n/a669d |
JDOC | IHE | |
Last sale 3/13/2026 at 1:30 PM | $55.49 | $86.56 |
| Previous close 03/12/2026 | $55.86 | $86.66 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
JDOC | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
JDOC | IHE | |
|---|---|---|
| Last price | $55.49 | $86.56 |
| 1D performance | -0.65% | -0.12% |
| AuM | $8.33 M | $995.33 M |
| E/R | 0.65% | 0.38% |
JDOC | IHE | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | J.P. Morgan Asset Management | iShares |
| Benchmark | - | Dow Jones U.S. Select Pharmaceuticals Index |
| N° of holdings | 53 | 46 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 1, 2023 | May 1, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the JDOC and IHE ETFs performed in 2026?
As of March 13, 2026, JDOC is down -4.05% year-to-date (YTD), while IHE has returned 2.1%. That puts IHE better performer ahead so far this year.
Which ETF is attracting more investor money: JDOC or IHE?
Year-to-date, the JDOC ETF saw - in flows, compared to +$129M for IHE.
Which ETF is more volatile: JDOC or IHE?
Over the past year, JDOC had a volatility of 16.33%, while IHE experienced 20.46%.
Which ETF is bigger: JDOC or IHE?
As of March 13, 2026, JDOC holds $8.33 M in assets under management (AUM), while IHE manages $995.33 M.
What sectors do the JDOC and IHE ETFs invest in?
JDOC leans toward sectors like Health Care. Meanwhile, IHE focuses on Health Care.
What are the top holdings of the JDOC ETF and IHE ETF?
JDOC top holdings include JOHNSON&JOHNSON, LILLY and ABBVIE. IHE holds in its top three: JOHNSON&JOHNSON, LILLY and MERCK & CO INC.
Which ETF is more diversified: JDOC or IHE?
JDOC holds 58 securities with 57.94% of its assets in the top 15. IHE has 56 securities and a top 15 weight of 84.8%.
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
Healthcare Stocks Rebound
Health is Wealth: A look at the Healthcare Sector
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
